Kk. Gnanalingham et al., DIFFERENTIAL ANTI-PARKINSONIAN EFFECTS OF BENZAZEPINE D-1 DOPAMINE AGONISTS WITH VARYING EFFICACIES IN THE MPTP-TREATED COMMON MARMOSET, Psychopharmacology, 117(3), 1995, pp. 275-286
In common marmosets systemically treated with MPTP (1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine), the behavioural effects of benzazepine D-
1 dopamine (DA) agonists with full/supramaximal (SKF 80723 and SKF 829
58), partial (SKF 38393, SKF 75670 and SKF 83565) and no efficacies (S
KF 83959) in stimulating adenylate cyclase (AC) activity were investig
ated. The benzazepine derivatives, with the exception of SKF 82958 (8
fold D-1 DA receptor selectivity), demonstrated high D-1 DA receptor a
ffinity and selectivity (approximately 100 fold or more) in rat striat
al homogenates. Administration of MPTP in marmosets induced locomotor
hypoactivity, rigidity and motor disability. SKF 38393 roxy-1-phenyl-2
,3,4,5-tetrahydro-1H-3-benzazepine) and SKF 75670 (3-CH3 analogue) fur
ther reduced locomotor activity (by - 70 to - 80%) and increased motor
disability (by +22 to +67%) in these animals. SKF 83565 (6-Cl, 3-CH3,
3'-Cl analogue) and SKF 82958 (6-Cl, 3-C3H5 analogue) had only a slig
ht effect on locomotor activity but decreased motor disability at high
doses (-46 to -60%). In contrast, SKF 83959 (6-Cl, 3-CH3, 3'-CH3 anal
ogue) and SKF 80723 (6-Br analogue) produced pronounced increases in l
ocomotion (6-10 fold) and a reversal in motor disability (by -64 to -7
7%). Oral activity, consisting largely of abnormal, 'dyskinetic' tongu
e protrusions and vacuous chews, was increased in animals treated with
SKF 38393, SKF 83565, SKF 82958 and more especially with SKF 80723 an
d SKF 83959. Grooming was increased with SKF 82958 and more especially
with SKF 80723 and SKF 83959. In contrast, quinpirole (D-2 DA agonist
), reversed the MPTP-induced motor deficits in the marmoset, with no e
ffect on grooming and oral activity. The present findings further demo
nstrate the antiparkinsonian actions of some D-1 DA agonists in MPTP-t
reated primates. However, in general the behavioural effects of benzaz
epines failed to correlate with either their D-1 DA receptor affinity/
selectivity or their efficacy in stimulating adenylate cyclase (AC) ac
tivity. These observations further implicate a behavioural role for D-
1 DA receptors uncoupled to AC and/or a role for extrastriatal D-1 DA
receptors in mediating the behavioural response to D-1 DA agonists.